Water maze impairments after combined depletion of somatostatin and serotonin in the rat

Behavioural Brain Research

Volumn 181, Issue 1, 2007, Pages 85-95

  Dyer, Kelly ^a   Cain, Donald P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Acetylcholine; Nonspatial pretraining; Reversal training; Serotonin; Somatostatin; Spatial navigation; Spatial training

Indexed keywords

FENCLONINE; MERCAPTAMINE; SCOPOLAMINE; SEROTONIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HORMONE DETERMINATION; HORMONE RELEASE; LEARNING; LOW DRUG DOSE; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; SPATIAL MEMORY; SPATIAL ORIENTATION; SWIMMING; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; CYSTEAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FENCLONINE; LEARNING DISORDERS; MALE; MAZE LEARNING; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; SCOPOLAMINE; SEROTONIN; SEROTONIN ANTAGONISTS; SOMATOSTATIN; TIME FACTORS;

EID: 34248662944     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.03.029     Document Type: Article

References (64)

1. AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer disease: randomized double-blind trial. Lancet 363 (2004) 2105-2115
2. Araujo D.M., Lapchak P.A., Collier B., and Quirion R. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus. J Neurochem 55 (1990) 1546-1555
3. Baker G.B., and Reynolds G.P. Biogenic amines and their metabolites in Alzheimer's disease: noreadrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata. Neurosci Lett 100 (1989) 335-339
4. Bannerman D.M., Good M.A., Butcher S.P., Ramsay M., and Morris R.G.M. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378 (1995) 182-186
5. Beiko J., Candusso L., and Cain D.P. The effect of nonspatial water maze pretraining in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioral assessment of spatial performance. Behav Brain Res 88 (1997) 201-211
6. Beiko J., Lander R., Hampson E., Boon F., and Cain D.P. Contribution of sex differences in the acute stress response to sex differences in water maze performance in the rat. Behav Brain Res 151 (2004) 239-253
7. Bodenant C., Leroux P., Gonzalez B.J., and Vaudry H. Transient expression of somatostatin receptors in the rat visual system during development. Neuroscience 41 (1991) 595-606
8. Cain D.P. Prior non-spatial pretraining eliminates sensorimotor disturbances and impairments in water maze learning caused by diazepam. Psychopharmacology 130 (1997) 313-319
9. Cain D.P. Testing the NMDA, long-term potentiation and cholinergic hypotheses of spatial learning. Neurosci Biobehav Rev 22 (1998) 181-193
10. Cain D.P., and Boon F. Detailed behavioral analysis reveals both task strategies and spatial impairments in rats given bilateral middle cerebral artery stroke. Brain Res 972 (2003) 64-74
11. Cain D.P., Boon F., and Corcoran M.E. Thalamic and hippocampal mechanisms in spatial navigation: a dissociation between brain mechanisms for learning how versus learning where to navigate. Behav Brain Res 170 (2006) 241-256
12. Cain D.P., Ighanian K., and Boon F. Individual and combined manipulation of muscarinic, NMDA, and benzodiazepine receptor activity in the water maze task: implications for a rat model of Alzheimer dementia. Behav Brain Res 111 (2000) 125-137
13. Cain D.P., Saucier D., and Boon F. Testing hypotheses of spatial learning: the role of NMDA receptors and NMDA-mediated long-term potentiation. Behav Brain Res 84 (1997) 179-193
14. Cain D.P., Saucier D., Hall J., Hargreaves E.L., and Boon F. Detailed behavioral analysis of water maze acquisition under APV or CNQX: contribution of sensorimotor disturbances to drug-induced acquisition deficits. Behav Neurosci 110 (1996) 86-102
15. Cain D.P., Saucier D., Hargreaves E.L., Wilson E., and De Souza J.F.X. Polypropylene pellets as an inexpensive reusable substitute for milk powder in the Morris water maze. J Neurosci Method 49 (1993) 193-197
16. Chattha G.K., and Beal M.F. Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomes. Brain Res 401 (1987) 359-364
17. Cook L.L., Bissette G., Dole K., and Nemeroff C. A critical evaluation of cysteamine as a tool to deplete somatostatin in the rat central nervous system. Endocrinology 124 (1989) 855-861
18. Davies P., Katzman R., and Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288 (1980) 279-280
19. Decker M.W., Gill T.M., and McGaugh J.L. Concurrent muscarinic and β-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance. Brain Res 513 (1990) 81-85
20. Decker M.W., and McGaugh J.L. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7 (1991) 151-168
21. De Deyn P.P., Rabheru K., Rasmussen A., Bocksberger J.P., Dautzenberg P.L.J., Eriksson S., et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53 (1999) 946-955
22. Dringenberg H.C., Hargreaves E.L., Baker G.B., Cooley R.K., and Vanderwolf C.H. p-chlorophenylalanine-induced serotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits. Behav Brain Res 68 (1995) 229-237
23. Fairburn G., and Hope R.A. Changes in behaviour in dementia: a neglected research area. Br J Psychiatry 152 (1988) 406-407
24. Fitzgerald L.W., and Dokla C.P.J. Morris water task impairment and hypoactivity following cysteamine-induced reductions of somatostatin-like immunoreactivity. Brain Res 505 (1989) 246-250
25. Harder J.A., Kelly M.E., Cheng C.H.K., and Costall B. Combined pCPA and muscarinic antagonist treatment produces a deficit in rat water maze acquisition. Pharmacol Biochem Behav 55 (1996) 61-65
26. Harker K.T., and Whishaw I.Q. Place and matching-to-place spatial learning affected by rat inbreeding (Dark-Agouti, Fischer 344) and albinism (Wistar, Sprague-Dawley) but not domestication (wild rat vs. Long-Evans, Fischer-Norway). Behav Brain Res 134 (2002) 467-477
27. Haroutunian V., Kanof P.D., and Davis K.L. Interactions of forebrain cholinergic and somatostatinergic systems in the rat. Brain Res 496 (1989) 98-104
28. Holscher C. Stress impairs performance in spatial water maze learning tasks. Behav Brain Res 100 (1999) 225-235
29. Hosli E., and Hosli L. Colocalization of binding sites for somatostatin, muscarine and nicotine on cultured neurones of rat neocortex, cerebellum, brain stem, and spinal cord: combined autoradiographic and immunohistochemical studies. Neurosci Lett 173 (1994) 71-74
30. Justino L., Welner S.A., Tannenbaum G.S., and Schipper H.M. Long-term effects of cysteamine on cognitive and locomotor behaviour in rats: relationship to hippocampal glial pathology and somatostatin levels. Brain Res 761 (1997) 127-134
31. Kalova E., Vlcek K., Jarolimova E., and Bures J. Allothetic orientation and sequential ordering of places is impaired in early stages of Alzheimer's disease: corresponding results in real space tests and computer tests. Behav Brain Res 159 (2005) 175-186
32. Lin M.T., Uang W.N., Ho L.T., Chuang J., Fan L.J., and Somatostatin:. A hypothalamic transmitter for theromoregulation in rats. Eur J Phys 413 (1989) 528-532
33. Matsuoka N., Yamazaki M., and Yamaguchi I. Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers. Neuroscience 66 (1995) 617-626
34. Monacelli A.M., Cushman L.A., Karcic V., and Duffy C.J. Spatial disorientation in Alzheimer's disease: the remembrance of things passed. Neurology 61 (2003) 1491-1497
35. Morris R.G.M. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Method 11 (1984) 47-60
36. Morris R.G.M. Synaptic plasticity and learning: selective impairments in rats and blockade of long term potentiation in vivo by the N-methyl-d-aspartate receptor antagonist AP5. J Neurosci 9 (1989) 3040-3057
37. Mouradian M.M., Blin J., Giuffra M., Heuser I.J.E., Baronti F., Ownby J., et al. Somatostatin replacement therapy for Alzheimer dementia. Ann Neurol 30 (1991) 610-613
38. Nilsson C.L., Brinkmalm A., Minthon L., Blennow K., and Ekman R. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Peptides 22 (2001) 2105-2112
39. Nilsson O.G., Strecker R.E., Daszuta A., and Bjorklund A. Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task. Brain Res 453 (1988) 235-246
40. Patel Y.C., and Pierzchala I. Cysteamine induces a loss of tissue somatostatin-28 when measured as somtostatin-28(15-28)-like immunoreactivity but not when assessed as somatostatin-28(1-14)-like immunoreactivity: evidence for the importance of the disulfide bond for cysteamine action. Endocrinology 116 (1985) 1699-1702
41. Perrot-Sinal T.S., Kosteniuk M.A., Ossenkopp K.P., and Kavaliers M. Sex differences in the Morris water maze and the effects of initial nonstationary hidden platform training. Behav Neurosci 110 (1996) 1309-1320
42. Prusky G.T., Harker K.T., Douglas R.M., and Whishaw I.Q. Variation in visual acuity within pigmented, and between pigmented and albino rat strains. Behav Brain Res 136 (2002) 339-348
43. Rakovska A., Javitt D., Raichev P., Ang R., Balla A., Aspromonte J., et al. Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic-cholinergic interaction. Brain Res Bull 61 (2003) 529-536
44. Richter-Levin G., and Segal M. Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission. Brain Res 477 (1989) 404-407
45. Riekkinen Jr. P., Riekkinen M., Sirvio J., and Riekkinen P. Effects of concurrent nicotinic antagonist and PCPA treatments on spatial and passive avoidance learning. Brain Res 575 (1992) 247-250
46. Riekkinen Jr. P., Sirvio J., and Riekkinen P. Interaction between raphe dorsalis and nucleus basalis magnocellularis in spatial learning. Brain Res 527 (1990) 342-345
47. Riekkinen M., Sirvio J., Toivanen T., and Riekkinen Jr. P. Combined treatment with a 5HT1a receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behaviour. Psychopharmacology 122 (1995) 137-146
48. Rossor M., and Iversen L.L. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. Br Med Bull 42 (1986) 70-74
49. Saber A., and Cain D.P. Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists. Neuropsychopharmacology 28 (2003) 1247-1256
50. Sagar S.M., Landry D., Millard W.J., Badger T.M., Arnold M., and Martin J.B. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine. J Neurosci 2 (1982) 225-231
51. Saucier D., and Cain D.P. Spatial learning without NMDA receptor-dependent long-term potentiation. Nature 378 (1995) 186-189
52. Saucier D., Hargreaves E.L., Boon F., Vanderwolf C.H., and Cain D.P. Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits. Behav Neurosci 110 (1996) 103-116
53. Tariot P.N., and Federoff H.J. Current treatment for Alzheimer disease and future prospects. Alzheimer Dis Assoc Disord 17 supplement 4 (2003) S105-S113
54. Teri L., Larson E.B., and Reifler B.V. Behavioral disturbance in dementia of the Alzheimer's type. J Am Geriatr Soc 36 (1988) 1-6
55. Vanderwolf C.H. Near-total loss of 'learning' and 'memory' as a result of combined cholinergic and serotonergic blockade in the rat. Behav Brain Res 23 (1987) 43-57
56. Vanderwolf C.H. Cerebral activity and behaviour: control by central cholinergic and serotonergic systems. Int Rev of Neurobiol 30 (1988) 225-340
57. Vanderwolf C.H. Effects of water temperature and core temperature on rat's performance in a swim-to-platform test. Behav Brain Res 44 (1991) 105-106
58. Vanderwolf C.H., and Baker G.B. The role of brain noradrenaline in cortical activation and behaviour: a study of lesions of the locus coeruleus, medial thalamus and hippocampus-neocortex and of muscarinic blockade in the rat. Behav Brain Res 78 (1996) 225-234
59. Vanderwolf C.H., Baker G.B., and Dickson C. Serotonergic control of cerebral activity and behavior: models of dementia. Ann NY Acad Sci 600 (1990) 366-383
60. Whishaw I.Q. Dissociating performance and learning deficits on spatial navigation tasks in rats subjected to cholinergic muscarinic blockade. Brain Res Bull 23 (1989) 347-358
61. Whishaw I.Q., and Tomie J.A. Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: evidence from sensory, motor, and acquisition tests in a swimming pool. Behav Neurosci 101 (1987) 603-616
62. Whishaw I.Q., Cassel J.C., and Jarrard L.E. Rats with fimbria-fornix lesions display a place response in a swimming pool: a dissociation between getting there and knowing where. J Neurosci 15 (1995) 5779-5788
63. Whishaw I.Q., and Jarrard L.E. Similarities vs. differences in place learning and circadian activity in rats after fimbria-fornix section or ibotenate removal of hippocampal cells. Hippocampus 5 (1995) 595-604
64. Yamazaki M., Matsuoka N., Maeda N., Ohkubo Y., and Yamaguchi I. FK960 N-(4-Aceytl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action. J Pharm Exp Ther 279 (1996) 1157-1173